Viewing Study NCT06479356

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-02-22 @ 6:45 PM
Study NCT ID: NCT06479356
Status: RECRUITING
Last Update Posted: 2024-08-21
First Post: 2024-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
Sponsor: Shanghai Ming Ju Biotechnology Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin Lymphoma View
None Large B-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None JWCAR029 View
None B-Cell Malignancies View
None CAR T cells View
None Chimeric antigen receptor View
None Relapsed/Refractory View